Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?

@inproceedings{Marchese2012DoesTA,
  title={Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?},
  author={Anna Marchese and Susanna Esposito and Ramona Barbieri and Matteo Bassetti and Eugenio A. Debbia},
  booktitle={BMC infectious diseases},
  year={2012}
}
BACKGROUND In several European Countries, by the end of 2012, CLSI guidelines will be replaced by EUCAST. We compared antimicrobial susceptibility results of a large number of respiratory pathogens using both EUCAST and previously adopted CLSI criteria to evaluate the impact on susceptibility patterns and the possible consequences that could occur in clinical practice due to this replacement.For S. pyogenes and S. aureus, the interpretation of susceptibility data using the EUCAST criteria did… CONTINUE READING